FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014986706> ?p ?o ?g. }

• W3014986706 endingPage "F1305" @default.
• W3014986706 startingPage "F1295" @default.
• W3014986706 abstract "Podocyte loss and proteinuria are both key features of human diabetic nephropathy (DN). The leptin-deficient BTBR mouse strain with the ob/ob mutation develops progressive weight gain, type 2 diabetes, and diabetic nephropathy that has many features of advanced human DN, including increased mesangial matrix, mesangiolysis, podocyte loss, and proteinuria. Selective antagonism of the endothelin-1 type A receptor (ET A R) by atrasentan treatment in combination with renin-angiotensin-aldosterone system inhibition with losartan has been shown to have the therapeutic benefit of lowering proteinuria in patients with DN, but the underlying mechanism for this benefit is not well understood. Using a similar therapeutic approach in diabetic BTBR ob/ob mice, this treatment regimen significantly increased glomerular podocyte number compared with diabetic BTBR ob/ob controls and suggested that parietal epithelial cells were a source for podocyte restoration. Atrasentan treatment alone also increased podocyte number but to a lesser degree. Mice treated with atrasentan demonstrated a reduction in proteinuria, matching the functional improvement reported in humans. This is a first demonstration that treatment with the highly selective ET A R antagonist atrasentan can lead to restoration of the diminished podocyte number characteristic of DN in humans and thereby underlies the reduction in proteinuria in patients with diabetes undergoing similar treatment. The benefit of ET A R antagonism in DN extended to a decrease in mesangial matrix as measured by a reduction in accumulations of collagen type IV in both the atrasentan and atrasentan + losartan-treated groups compared with untreated controls." @default.
• W3014986706 created "2020-04-10" @default.
• W3014986706 creator A5007845859 @default.
• W3014986706 creator A5022177889 @default.
• W3014986706 creator A5074003444 @default.
• W3014986706 creator A5079415345 @default.
• W3014986706 date "2020-05-01" @default.
• W3014986706 modified "2023-10-14" @default.
• W3014986706 title "Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy" @default.
• W3014986706 cites W1534850320 @default.
• W3014986706 cites W1899289933 @default.
• W3014986706 cites W1969567160 @default.
• W3014986706 cites W1983539151 @default.
• W3014986706 cites W1991210746 @default.
• W3014986706 cites W2002204248 @default.
• W3014986706 cites W2003450755 @default.
• W3014986706 cites W2007616702 @default.
• W3014986706 cites W2012922117 @default.
• W3014986706 cites W2016364106 @default.
• W3014986706 cites W2041308494 @default.
• W3014986706 cites W2042689611 @default.
• W3014986706 cites W2044877466 @default.
• W3014986706 cites W2051433485 @default.
• W3014986706 cites W2051719011 @default.
• W3014986706 cites W2060407689 @default.
• W3014986706 cites W2063013576 @default.
• W3014986706 cites W2063771744 @default.
• W3014986706 cites W2074692122 @default.
• W3014986706 cites W2075022360 @default.
• W3014986706 cites W2075837574 @default.
• W3014986706 cites W2076584321 @default.
• W3014986706 cites W2077012158 @default.
• W3014986706 cites W2078349330 @default.
• W3014986706 cites W2083805868 @default.
• W3014986706 cites W2091508721 @default.
• W3014986706 cites W2096179755 @default.
• W3014986706 cites W2100732774 @default.
• W3014986706 cites W2105790451 @default.
• W3014986706 cites W2106079757 @default.
• W3014986706 cites W2111346120 @default.
• W3014986706 cites W2121915301 @default.
• W3014986706 cites W2129137900 @default.
• W3014986706 cites W2135190643 @default.
• W3014986706 cites W2136089239 @default.
• W3014986706 cites W2138499748 @default.
• W3014986706 cites W2143431902 @default.
• W3014986706 cites W2143923014 @default.
• W3014986706 cites W2148643197 @default.
• W3014986706 cites W2148652246 @default.
• W3014986706 cites W2152298559 @default.
• W3014986706 cites W2155587088 @default.
• W3014986706 cites W2156753852 @default.
• W3014986706 cites W2159126069 @default.
• W3014986706 cites W2162196137 @default.
• W3014986706 cites W2166738550 @default.
• W3014986706 cites W2238778078 @default.
• W3014986706 cites W2327067198 @default.
• W3014986706 cites W2503728255 @default.
• W3014986706 cites W2562401512 @default.
• W3014986706 cites W2595201862 @default.
• W3014986706 cites W2779413173 @default.
• W3014986706 cites W2791421487 @default.
• W3014986706 cites W2925541246 @default.
• W3014986706 cites W2937955146 @default.
• W3014986706 cites W3003047159 @default.
• W3014986706 cites W2969485048 @default.
• W3014986706 doi "https://doi.org/10.1152/ajprenal.00498.2019" @default.
• W3014986706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32249614" @default.
• W3014986706 hasPublicationYear "2020" @default.
• W3014986706 type Work @default.
• W3014986706 sameAs 3014986706 @default.
• W3014986706 citedByCount "16" @default.
• W3014986706 countsByYear W30149867062020 @default.
• W3014986706 countsByYear W30149867062021 @default.
• W3014986706 countsByYear W30149867062022 @default.
• W3014986706 countsByYear W30149867062023 @default.
• W3014986706 crossrefType "journal-article" @default.
• W3014986706 hasAuthorship W3014986706A5007845859 @default.
• W3014986706 hasAuthorship W3014986706A5022177889 @default.
• W3014986706 hasAuthorship W3014986706A5074003444 @default.
• W3014986706 hasAuthorship W3014986706A5079415345 @default.
• W3014986706 hasConcept C126322002 @default.
• W3014986706 hasConcept C126894567 @default.
• W3014986706 hasConcept C134018914 @default.
• W3014986706 hasConcept C170493617 @default.
• W3014986706 hasConcept C2777146197 @default.
• W3014986706 hasConcept C2779561371 @default.
• W3014986706 hasConcept C2779922275 @default.
• W3014986706 hasConcept C2780091579 @default.
• W3014986706 hasConcept C2780288358 @default.
• W3014986706 hasConcept C2908929049 @default.
• W3014986706 hasConcept C555293320 @default.
• W3014986706 hasConcept C71924100 @default.
• W3014986706 hasConcept C98274493 @default.
• W3014986706 hasConceptScore W3014986706C126322002 @default.
• W3014986706 hasConceptScore W3014986706C126894567 @default.
• W3014986706 hasConceptScore W3014986706C134018914 @default.
• W3014986706 hasConceptScore W3014986706C170493617 @default.

• next